Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 1574 results found. Search for [ Indian pharma ]

Results 1 to 21 of 1574
E Kumar Sharma
New Delhi, November 21, 2018
Some of the leading Indian pharma companies are pitching in to cater to the markets that some of the big pharma companies are vacating as part of their product optimisation strategies.


BusinessToday.In
November 21, 2018
Suboxone is British drugmaker Indivior's best-selling opioid addiction treatment drug in the US. Shares of Indivior tanked about 47 percent on Tuesday, in a record single-day fall. Jefferies analysts said they consider the ruling to be near-term positive, and one that allows the company to immediately re-launch the product, but still at-risk.


Renu Yadav
November 20, 2018
The fund house believes that these are interesting times for Indian healthcare sector despite disappointing earnings in FY18. The sector has the potential to get re-rated after temporary disruptions get resolved


PTI
November 20, 2018



PTI
November 15, 2018



PTI
November 14, 2018



E Kumar Sharma
New Delhi, November 14, 2018
Traditionally strong recruiters are recalibrating their talent needs and hiring parameters. Other than from B-schools, some are laterally hiring specialists as well.


E Kumar Sharma
November 13, 2018
At the moment most experts are in a wait and watch mode, while some players from these sectors think that it could be a mixed bag.


BusinessToday.In
November 13, 2018
The stock was the top Sensex loser with a cut of 4.72% or 27.85 points to 561.70 level. On Nifty too, the stock was the top loser falling 4.75% to 561.50 level.  The stock has been losing for the last two days and has fallen 5.74% during the period. It hit an intra day low of 556.05, down 5.68%.


PTI
November 12, 2018



PTI
November 11, 2018



BusinessToday.In
New Delhi, November 9, 2018
Before the official announcement by PM Modi, the RBI's Central Board, in its meeting had differed with the government's claim that the note ban would curb black money circulation, citing that most cash was in the form of real estate.


PTI
November 2, 2018



PTI
November 2, 2018



BusinessToday.In
October 31, 2018
The brokerage is concerned about patchy monsoon, election season, rising twin deficits, high crude prices, weak INR, slowing Chinese economy, trade wars, etc.  It wonders whether the market will recover at all or whether a bear market is the next phase?


Anup Jayaram
New Delhi, October 29, 2018
The market cap of BT 500 companies rose 23.4 per cent during 2017/18, but things could get difficult going ahead.


PB Jayakumar
New Delhi, October 29, 2018
A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.


PTI
October 28, 2018



BusinessToday.In
October 26, 2018
After the Sensex lost 14% or 5,640 points and Nifty fell 14.71% or 1,730 points in less than two months, investors including Jhunjhunwala booked heavy losses in their portfolios.


PTI
October 26, 2018



PAGES 1 OF 79  12345